Antibody Drug Conjugates

I am Research. Progress. Hope.

PhRMA February 29, 2016

Imagine new medicines that effectively fight cancer, but may result in fewer side effects thanks to more accurate targeting of tumor cells. Currently being investigated by several of our member companies, including Pfizer, antibody drug conjugates may be more effective in targeting and destroying tumors when used in combination with current therapies, such as chemotherapy.

ADCs represent a continuing shift in the cancer treatment landscape toward personalized medicines that more accurately attack specific targets fueling cancer cell growth while leaving healthier cells unharmed.